| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 41 |
| 1 | METHOTREXATE SODIUM | 37 |
| 2 | METHOTREXATE | 30 |
| 3 | UPADACITINIB | 23 |
| 4 | TACROLIMUS | 22 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 21 |
| 6 | TACROLIMUS OINTMENT 0.1% | 21 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 20 |
| 8 | FINGOLIMOD HCL | 19 |
| 9 | MYCOPHENOLATE MOFETIL | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOCILIZUMAB-AAZG | 1 | 0.0016 |
| 1 | ARSENIC TRIOXIDE | 3 | 0.0013 |
| 2 | PINDOLOL | 1 | 0.0012 |
| 3 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 4 | MIRIKIZUMAB-MRKZ | 1 | 0.0011 |
| 5 | MOGAMULIZUMAB-KPKC | 1 | 0.0007 |
| 6 | WHITE PETROLATUM | 1 | 0.0007 |
| 7 | ANIDULAFUNGIN | 1 | 0.0006 |
| 8 | FEBUXOSTAT TABLETS 40 MG | 6 | 0.0006 |
| 9 | AMPHOTERICIN B LIPOSOME | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 10 | 0.0003 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 6 | 0.0003 |
| 3 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 5 | Janus Kinase Inhibitor [EPC] | 27 | 0.0002 |
| 6 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 7 | P2Y12 Platelet Inhibitor [EPC] | 13 | 0.0001 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 5 | 0.0001 |
| 9 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |